Skip to content

Clinical trials

Phase 1 Urinary Bladder Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1 Country / region: Australia Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20151
20182
20202
20212
20221
20235
20248
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting7
Recruiting6
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Arcus Biosciences, Inc.2
MacroGenics2
Monopar Therapeutics2
Novartis Pharmaceuticals2
Actym Therapeutics, Inc.1
Asieris Pharmaceuticals (AUS) Pty Ltd.1
Aura Biosciences1
BeiGene1
Corvus Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms25
Ovarian Neoplasms13
Carcinoma, Non-Small-Cell Lung11
Breast Neoplasms10
Colorectal Neoplasms10
Pancreatic Neoplasms10
Stomach Neoplasms10
Uterine Cervical Neoplasms10
Lung Neoplasms9
Squamous Cell Carcinoma of Head and Neck9

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.